Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Can football conquer the US? Why culture is key this World Cup

      GettyImages 2281127577 featuring a significant news event or business setting, capturing key moments and interactions

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Can football conquer the US? Why culture is key this World Cup

      GettyImages 2281127577 featuring a significant news event or business setting, capturing key moments and interactions

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      The best places to eat sandwiches in Lisbon, from bifanas to pregos

      Bifana do Afonsos famous bifana sandwich showcasing tender pork in a freshly baked roll with savory sauce.

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Tuesday 14 April 2026 4:13 pm

Acumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization

Acumetis – a new global commercialization company for the life sciences industry – launches today. The company, formed as a combination of five well-known specialist consultancies – Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group – will provide enhanced strategic clarity and critical connection for life sciences businesses with products at all stages of development.

Acumetis is built around a single integrated commercial model and one leadership team, bringing together commercial, insights, medical, market access and patient strategy under one roof. The business offers capability and data to support clients across the product lifecycle, from evaluation and market access strategy through to launch execution and in-market performance.

Acumetis is purposefully built for the demands of modern life sciences commercialization. The name reflects the company’s founding philosophy. ‘Acumen’ – the ability to make good judgments and discern what really matters – and ‘Metis’, the Greek concept of practical wisdom, together define an approach built on rigorous analysis, connected expertise, and measurable results for clients.

Brent Herspiegel, CEO of Acumetis, said: “Acumetis is designed to set a new standard in commercialization. Not just in capability, but in how that capability is delivered. For over two decades, the businesses that form Acumetis have supported more than 200 product launches for some of the most complex and high-stakes assets in life sciences. We’re now bringing our clients our full expertise as one integrated brand, helping them to make the right decision at the moments that matter most. For life sciences companies facing compressed timelines, increasing regulatory complexity and rising pressure to demonstrate value, this is a compelling value proposition.”

As a combined business, Acumetis will employ more than 350 specialists globally, with operational experience spanning more than 50 geographic markets. The company’s client base already includes more than 150 life sciences organizations, among them many of the world’s top global pharmaceutical companies. The founding businesses have collectively supported more than 200 product launches and years of commercialization success.

The company is backed by DFW Capital, a leading middle-market private equity firm investing in companies that provide outsourced business, industrial, or healthcare services in regulated, compliance driven end-markets.

Acumetis is headquartered in Yardley, Pennsylvania, with additional offices across the United States, Canada, South America, United Kingdom, Europe and India. The company’s website launches today at www.acumetisglobal.com.

Further information is available at www.acumetisglobal.com. Media enquiries should be directed to [email protected].

About Acumetis

Acumetis is a global expert commercialization partner purposefully built to help life sciences win in the age of connectivity. With an integrated model spanning the entire asset lifecycle, deep functional and therapeutic-area expertise, and rigorous, outcome-driven thinking, Acumetis reframes complex problems and shapes solutions that are both imaginative and achievable. With more than 350 experts globally and experience across 50+ geographic markets, Acumetis helps clients unlock value, accelerate performance, and deliver better outcomes for patients.

Acumetis. Reframe what’s possible.

About DFW Capital

DFW Capital Partners is a middle-market private equity firm with over $2 billion in assets under management. The firm’s focus for the past 20 years has been investing in founder or management owned companies that provide outsourced business, industrial, or healthcare services in regulated, compliance driven end-markets.

Acumetis brand launch event showcasing pharmaceutical and biotech leaders uniting for life sciences commercialization

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414569348/en/

Contact

[email protected]
+44 7861995400

Abstract

LEADING PHARMACEUTICAL AND BIOTECH CONSULTANCIES COMBINE TO CREATE A FULL-SERVICE COMMERCIALIZATION POWERHOUSE, ACUMETIS

TweetText

Acumetis is formed as a combination of five well-known specialist consultancies – Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group.

Company Logo
Company Logo
Read more

Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Merger/Acquisition

Trending Articles

  • Can football conquer the US? Why culture is key this World Cup

  • Starmer agrees investment deal with Japan as EU deal questioned

  • Elon Musk becomes world’s first trillionaire after SpaceX mega float

  • US and Iran agree to peace deal’s text, negotiators say

  • Thames Water, energy grid, rent prices: Burnham drums up public control agenda

More from CityAM

  • Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

    Business Wire
  • Ennov Announces Strategic Growth Investment from Bregal Sagemount and Ardian

    Business Wire
  • Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent

    Business Wire
  • Winston Taylor Completes Historic Transatlantic Combination

    Business Wire
  • H55 Delivers Certification-Grade Propulsion Battery Modules to Pratt & Whitney Canada, Supporting Demonstration of Hybrid-Electric Aircraft Technology

    Business Wire
  • True Establishes Global Longevity Practice to Place Leaders Redefining Health, Aging, and Human Potential

    Business Wire
  • Milliman Financial Strategies Limited launches MGTS Milliman SmartShield Fund in UK

    Business Wire
  • British Land and RLAM secure robotics AI firm for London ‘innovation’ cluster

    Tech
    Humanoid robot 1TS by SKL Robotics in a tech lab setting, showcasing advanced robotics technology and innovation.
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited